OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial
Arianna Di Stadio, Luca D’Ascanio, Luigi Angelo Vaira, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 10, pp. 2001-2012
Open Access | Times Cited: 82
Arianna Di Stadio, Luca D’Ascanio, Luigi Angelo Vaira, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 10, pp. 2001-2012
Open Access | Times Cited: 82
Showing 1-25 of 82 citing articles:
Olfactory training – Thirteen years of research reviewed
Michał Pieniak, Anna Oleszkiewicz, Vittoria Avaro, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104853-104853
Open Access | Times Cited: 62
Michał Pieniak, Anna Oleszkiewicz, Vittoria Avaro, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104853-104853
Open Access | Times Cited: 62
Clinical trials on the pharmacological treatment of long COVID: A systematic review
Ying Jie Chee, Bingwen Eugene Fan, Barnaby Edward Young, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 60
Ying Jie Chee, Bingwen Eugene Fan, Barnaby Edward Young, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 60
Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study
Pietro De Luca, Angelo Camaioni, Pasquale Marra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2552-2552
Open Access | Times Cited: 57
Pietro De Luca, Angelo Camaioni, Pasquale Marra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2552-2552
Open Access | Times Cited: 57
Use of platelet‐rich plasma for COVID‐19–related olfactory loss: a randomized controlled trial
Carol H. Yan, Sophie S. Jang, Hung‐Fu C. Lin, et al.
International Forum of Allergy & Rhinology (2022) Vol. 13, Iss. 6, pp. 989-997
Open Access | Times Cited: 43
Carol H. Yan, Sophie S. Jang, Hung‐Fu C. Lin, et al.
International Forum of Allergy & Rhinology (2022) Vol. 13, Iss. 6, pp. 989-997
Open Access | Times Cited: 43
Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction
Lorenzo Muccioli, Giovanni Sighinolfi, Micaela Mitolo, et al.
NeuroImage Clinical (2023) Vol. 38, pp. 103410-103410
Open Access | Times Cited: 33
Lorenzo Muccioli, Giovanni Sighinolfi, Micaela Mitolo, et al.
NeuroImage Clinical (2023) Vol. 38, pp. 103410-103410
Open Access | Times Cited: 33
Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms after COVID-19: a systematic review
Hannelore Dillen, Geertruida E Bekkering, Sofie Gijsbers, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Hannelore Dillen, Geertruida E Bekkering, Sofie Gijsbers, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis
Maria Teresa Rocchetti, Francesco Bellanti, Mariia Zadorozhna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8824-8824
Open Access | Times Cited: 21
Maria Teresa Rocchetti, Francesco Bellanti, Mariia Zadorozhna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8824-8824
Open Access | Times Cited: 21
Application of Luteolin in Neoplasms and Nonneoplastic Diseases
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 21
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 21
Flavonoids derived from medicinal plants as a COVID ‐19 treatment
Mentor Sopjani, Francesca Falco, Federica Impellitteri, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1589-1609
Open Access | Times Cited: 8
Mentor Sopjani, Francesca Falco, Federica Impellitteri, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1589-1609
Open Access | Times Cited: 8
Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV ‐2) binding to angiotensin‐converting enzyme 2
Junjie Zhu, Huimin Yan, Mengyao Shi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3508-3521
Closed Access | Times Cited: 16
Junjie Zhu, Huimin Yan, Mengyao Shi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3508-3521
Closed Access | Times Cited: 16
Harnessing Luteolin's therapeutic potential in human disorders: Medicinal significance, biological, clinical properties and analytical aspects
Abhishek Singh, Seema Yadav, Prateek Pathak, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100401-100401
Open Access | Times Cited: 5
Abhishek Singh, Seema Yadav, Prateek Pathak, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100401-100401
Open Access | Times Cited: 5
Current landscape of long COVID clinical trials
Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111930-111930
Closed Access | Times Cited: 5
Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111930-111930
Closed Access | Times Cited: 5
Luteolin alleviates olfactory dysfunction in eosinophilic chronic rhinosinusitis through modulation of the TLR4/NF-κB signaling pathway
Jiali Shi, Li Dai, Jun Gu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114189-114189
Closed Access
Jiali Shi, Li Dai, Jun Gu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114189-114189
Closed Access
Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases
Jialian Lv, Xinyue Song, Zixin Luo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Jialian Lv, Xinyue Song, Zixin Luo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome
Viviana Versace, Paola Ortelli, Sabrina Dezi, et al.
Clinical Neurophysiology (2022) Vol. 145, pp. 81-88
Open Access | Times Cited: 26
Viviana Versace, Paola Ortelli, Sabrina Dezi, et al.
Clinical Neurophysiology (2022) Vol. 145, pp. 81-88
Open Access | Times Cited: 26
Post-viral olfactory loss and parosmia
Zhen Yu Liu, Luigi Angelo Vaira, Paolo Boscolo‐Rizzo, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000382-e000382
Open Access | Times Cited: 14
Zhen Yu Liu, Luigi Angelo Vaira, Paolo Boscolo‐Rizzo, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000382-e000382
Open Access | Times Cited: 14
Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies
Anna Paola Capra, Alessio Ardizzone, Lelio Crupi, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2189-2189
Open Access | Times Cited: 13
Anna Paola Capra, Alessio Ardizzone, Lelio Crupi, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2189-2189
Open Access | Times Cited: 13
Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics
Elena Cantone, Luca D’Ascanio, Pietro De Luca, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 7, pp. 3671-3678
Open Access | Times Cited: 4
Elena Cantone, Luca D’Ascanio, Pietro De Luca, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 7, pp. 3671-3678
Open Access | Times Cited: 4
Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial
Arianna Di Stadio, Salvatore Gallina, Salvatore Cocuzza, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 280, Iss. 11, pp. 4949-4961
Open Access | Times Cited: 11
Arianna Di Stadio, Salvatore Gallina, Salvatore Cocuzza, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 280, Iss. 11, pp. 4949-4961
Open Access | Times Cited: 11
Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) – protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)
Caroline Tengelmann, Stefanie Joos, Yvonne Kaußner, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Caroline Tengelmann, Stefanie Joos, Yvonne Kaußner, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Co-ultraPEALut in Subjective Cognitive Impairment Following SARS-CoV-2 Infection: An Exploratory Retrospective Study
Valentina Cenacchi, Giovanni Furlanis, Alina Menichelli, et al.
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 293-293
Open Access | Times Cited: 3
Valentina Cenacchi, Giovanni Furlanis, Alina Menichelli, et al.
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 293-293
Open Access | Times Cited: 3
Strategies for the Management of Spike Protein-Related Pathology
Matthew Halma, Christof Plothe, Paul E. Marik, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1308-1308
Open Access | Times Cited: 9
Matthew Halma, Christof Plothe, Paul E. Marik, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1308-1308
Open Access | Times Cited: 9
Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out
Gabriele Riccardi, Giovanni Francesco Niccolini, Mario Giuseppe Bellizzi, et al.
Diseases (2023) Vol. 11, Iss. 2, pp. 79-79
Open Access | Times Cited: 9
Gabriele Riccardi, Giovanni Francesco Niccolini, Mario Giuseppe Bellizzi, et al.
Diseases (2023) Vol. 11, Iss. 2, pp. 79-79
Open Access | Times Cited: 9
Phytochemicals, Biological Activities, Molecular Mechanisms, and Future Prospects of Plantago asiatica L.
Shi‐Yuan Wen, Bingyan Wei, Jieqiong Ma, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 71, Iss. 1, pp. 143-173
Closed Access | Times Cited: 14
Shi‐Yuan Wen, Bingyan Wei, Jieqiong Ma, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 71, Iss. 1, pp. 143-173
Closed Access | Times Cited: 14
Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?
Arianna Di Stadio, Evanthia Bernitsas, Ignazio La Mantia, et al.
Life (2023) Vol. 13, Iss. 1, pp. 226-226
Open Access | Times Cited: 8
Arianna Di Stadio, Evanthia Bernitsas, Ignazio La Mantia, et al.
Life (2023) Vol. 13, Iss. 1, pp. 226-226
Open Access | Times Cited: 8
